CYLD and adult T-cell leukemia/lymphoma: Phosphorylation of CYLD by IKKε promotes cell transformation by increasing NF-κB activation [104], but the presence of the IKK inhibitors leads to apoptosis indicating that CYLD may be a novel therapeutic target for adult T-cell leukemia [31].